Showing results (4931-4940 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|August 21, 2013
β-Catenin mutation status and outcomes in sporadic desmoid tumorsJohn T Mullen, Thomas F DeLaney, Andrew E Rosenberg, et al.
The Oncologist|June 4, 2013
Genomics of squamous cell lung cancerMelissa Rooney, Siddhartha Devarakonda, Ramaswamy Govindan
The Oncologist|July 2, 2013
Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimens in patients with node-positive and high-risk node-negative, HER2-positive early breast cancer: results from the BCIRG 006 StudyHeather-Jane Au, Wolfgang Eiermann, Nicholas J Robert, et al.
The Oncologist|April 26, 2013
Targeted therapies in neuroendocrine tumors (NET): clinical trial challenges and lessons learnedJames C Yao, Diane Reidy Lagunes, Matthew H Kulke
The Oncologist|April 26, 2013
Organ preservation for adenoid cystic carcinoma of the larynxKrzysztof J Misiukiewicz, Nadia Camille, Roy Tishler, et al.
The Oncologist|May 8, 2012
Association of HER-2 copy number and HER-2/CEP-17 ratio with neoadjuvant taxane-containing chemotherapy sensitivity in locally advanced breast cancerKe-Da Yu, Guang-Yu Liu, Xiao-Yan Zhou, et al.
The Oncologist|May 29, 2012
A pilot study of a culturally targeted video intervention to increase participation of African American patients in cancer clinical trialsDeliya R Banda, Alexander V Libin, Hong Wang, et al.
The Oncologist|May 16, 2012
High ERK protein expression levels correlate with shorter survival in triple-negative breast cancer patientsChandra Bartholomeusz, Ana M Gonzalez-Angulo, Ping Liu, et al.
The Oncologist|May 25, 2012
A randomized, phase II trial of standard triweekly compared with dose-dense biweekly capecitabine plus oxaliplatin plus bevacizumab as first-line treatment for metastatic colorectal cancer: XELOX-A-DVS (dense versus standard)Herbert Hurwitz, Edith P Mitchell, Thomas Cartwright, et al.
The Oncologist|November 13, 2013
Advancing cervical cancer prevention in India: implementation science prioritiesSuneeta Krishnan, Emily Madsen, Deborah Porterfield, et al.
Pageof 571